Jeff Mahan

Arlington, Virginia, United States Contact Info
500+ connections

Join to view profile
Inspire

Activity

Join now to see all activity

Experience & Education

  • Inspire

View Jeff’s full experience

See their title, tenure and more.

or

By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.

Publications

  • Enabling Social Listening for Cardiac Safety Monitoring: Proceedings from a DIA-CSRC Co-sponsored Think Tank

    American Heart Journal

    This White Paper provides a summary of the presentations and discussions from a think tank on Enabling Social Listening for Cardiac Safety Monitoring Trials that was co-sponsored by the Drug Information Association (DIA) and the Cardiac Safety Research Consortium, and held at the White Oak headquarters of the United States Food and Drug Administration (FDA) on 3rd June 2016. The meeting's goals were to explore current methods of collecting and evaluating social listening data and to consider…

    This White Paper provides a summary of the presentations and discussions from a think tank on Enabling Social Listening for Cardiac Safety Monitoring Trials that was co-sponsored by the Drug Information Association (DIA) and the Cardiac Safety Research Consortium, and held at the White Oak headquarters of the United States Food and Drug Administration (FDA) on 3rd June 2016. The meeting's goals were to explore current methods of collecting and evaluating social listening data and to consider their applicability to cardiac safety surveillance. Social listening is defined as the act of monitoring public postings on the internet. It has several theoretical advantages for drug and device safety. First, these include the ability to detect adverse events that are “missed” by traditional sources and the ability to detected adverse events sooner than would be allowed by traditional sources, both by affording near-real-time access to data from culturally- and geographically-diverse sources. Social listening can also potentially introduce a novel patient voice into the conversation about drug safety, which could uniquely augment understanding of real-world medication use obtained from more traditional methodologies. Finally, it can allow access to information about drug misuse and diversion. To date, the latter two of these have been realized.

    Other authors
    See publication

  • Learning by Listening, Digitally

    Value & Outcomes Spotlight

    The authors explore the value of anonymized social media data for insights into patients' use of medicines.

    Other authors
    See publication

Recommendations received

1 person has recommended Jeff

Join now to view

More activity by Jeff

View Jeff’s full profile

  • See who you know in common
  • Get introduced
  • Contact Jeff directly
Join to view full profile

Other similar profiles

Explore collaborative articles

We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.

Explore More

Others named Jeff Mahan in United States

62 others named Jeff Mahan in United States are on LinkedIn

See others named Jeff Mahan

Add new skills with these courses

See all courses